The clearest way to find out is a consultation
Is semaglutide for weight loss safe
Patients should be aware of important safety considerations: Stop treatment and seek urgent care for severe persistent abdominal pain (possible pancreatitis) Be alert to symptoms of gallbladder disease (right upper abdominal pain, fever, jaundice) Maintain adequate hydration to reduce the risk of acute kidney injury If you have diabetes and also take insulin or sulfonylureas, your prescriber may need to reduce these doses to prevent hypoglycaemia Use barrier contraception for 4 weeks after starting treatment and after each dose increase, as Mounjaro may reduce the effectiveness of oral contraceptives Mounjaro is not recommended during pregnancy or breastfeeding Regular monitoring of weight, blood pressure, and metabolic parameters is recommended, with healthcare professional review at least every 3 months to assess response and tolerability, in line with NICE guidance and the BNF

These numbers represent burping in general, not sulfur burps specifically, but sulfur burps are a subset of the broader burping reported in trials
Taking the Next Step Safely Weight loss is a journey that involves the whole body
Key questions that remain unanswered for danuglipron include: Long-term weight maintenance beyond one year Cardiovascular outcomes and mortality benefits Comparative effectiveness against established injectable GLP-1 therapies Real-world adherence rates and tolerability in broader populations Patients and healthcare professionals should await peer-reviewed publication of complete trial data before drawing definitive conclusions about danuglipron's clinical utility